Norgine recognised for excellence in health and safety with RoSPA Gold Medal Award fifth year in a row

19 June 2019



AMSTERDAM, Netherlands, 19th June 2019, 10:00 CET. NORGINE B.V. was handed  a prestigious award in recognition of its practices and achievements in health and safety management systems, such as leadership and workforce involvement.

For five years consistently, Norgine has achieved a Gold Medal in the internationally-renowned RoSPA Health and Safety Awards, the longest-running industry awards scheme in the UK. Norgine’s manufacturing sites based in Hengoed, Wales and Dreux, France demonstrated exceptional performance in enabling their staff “get home safely at the end of every working day”.

Philippe Caroff, Chief Manufacturing Officer at Norgine commented, “The award demonstrates the common dynamic approach across our global manufacturing and our strong commitment to health and safety, enabling our staff to deliver transformative medicines that help patients around the world. The Norgine B.V. group is a fully integrated pharmaceutical business, with manufacturing in both Hengoed, Wales and Dreux, France, third party supply networks and significant product development capabilities, in addition to our sales and marketing infrastructure. This year we celebrated 50 years in Hengoed and we always look forward to continuous improvement and raising the standards in manufacturing excellence even more in the future.”

Norgine has been researching and manufacturing innovative medicines in Hengoed and Dreux since the 1960’s. Manufacturing takes place 24 hours a day, 7 days a week to supply medicines around the globe and every year Norgine helps around 23 million patients worldwide.

Julia Small, RoSPA’s Head of Qualifications, Awards and Events said, “The RoSPA Awards have become the key fixture in the health and safety calendar. Highly-respected, with almost 2,000 entrants every year, RoSPA award winners benefit from the wide-ranging rewards of improved sector reputation.”

Norgine during the award ceremony at ExCeL, London on Tuesday, June 18, 2019



Media Contacts:

For further information please contact:

Eleni Fistikaki +44 (0)1895 826227 or +44 (0)7825 389477

Clara Bentham +44 (0)1895 826654 or +44 (0)7734 367883

Follow us @norgine


Notes to Editors:

About Norgine

Norgine is a leading European specialist pharmaceutical company with a direct commercial presence in all major European markets. Norgine specialises in gastroenterology, hepatology, cancer and supportive care.  In 2018, Norgine’s total net product sales were EUR 395 million, up 15 per cent.

Norgine employs over 1,300 people across its commercial, development and manufacturing operations and manages all aspects of product development, production, marketing, sale and supply.

In 2012, Norgine established a complementary business, Norgine Ventures, supporting innovative healthcare companies through the provision of debt-like financing in Europe and the US. For more information, please visit

NORGINE and the sail logo are trademarks of the Norgine group of companies.

About RoSPA Awards

The majority of awards are non-competitive and mark achievement at merit, bronze, silver and gold levels. Gold medals, president’s awards, orders of distinction and the Patron’s Award are presented to organisations sustaining the high standards of the gold level over consecutive years.

Competitive awards go to the best entries in 24 industry sectors including construction, healthcare, transport and logistics, engineering, manufacturing and education.

There are specialist awards for health at work, environmental management and fleet safety, and excellence trophies for the best international, new entry, workforce involvement and organisation operating or based in Scotland. RoSPA’s top accolade is the Sir George Earle Trophy.

Headline sponsor of the RoSPA Awards 2019 is NEBOSH – the National Examination Board in Occupational Safety and Health – for the 14th consecutive year.

For more information about the RoSPA Awards visit